[Fibrinolysis: indications in ophthalmology]

Bull Soc Belge Ophtalmol. 1993;247(1):71-3.
[Article in French]

Abstract

The ability to realize a microcatheter urokinase infusion in central retinal artery occlusion open new ways in therapy. It provides opportunity to realize in situ thrombolysis without well-known systemic side-effects. If started during the first hours after the occlusion, that therapy could be successful and give good visual prognosis.

MeSH terms

  • Angiography / methods
  • Humans
  • Infusions, Parenteral
  • Ophthalmic Artery / diagnostic imaging
  • Retinal Artery Occlusion / drug therapy*
  • Urokinase-Type Plasminogen Activator / administration & dosage
  • Urokinase-Type Plasminogen Activator / therapeutic use*

Substances

  • Urokinase-Type Plasminogen Activator